Skip to main navigation Skip to search Skip to main content

The development of chitosan based microcapsules as delivery vehicles for orally administered daunorubicin

  • P. L. Lam
  • , K. K.H. Lee
  • , Y. W. Ho
  • , R. S.M. Wong
  • , S. W. Tong
  • , C. H. Cheng
  • , K. H. Lam
  • , Cheuk On Tang
  • , Z. X. Bian
  • , R. Gambari
  • , S. H.L. Kok
  • , C. H. Chui

Research output: Journal article publicationJournal articleAcademic researchpeer-review

Abstract

This study reports the use of chitosan microcapsules for daunorubicin delivery via an oral route. The potential oral delivery of the daunorubicin/chitosan microcapsules was examined using an in vivo athymic nude mice xenograft model with Non-Hodgkin's lymphoma cells. Microencapsulated daunorubicin could be administered orally with tumour growth inhibition activity.
Original languageEnglish
Pages (from-to)14109-14114
Number of pages6
JournalRSC Advances
Volume4
Issue number27
DOIs
Publication statusPublished - 1 Jan 2014

ASJC Scopus subject areas

  • General Chemistry
  • General Chemical Engineering

Fingerprint

Dive into the research topics of 'The development of chitosan based microcapsules as delivery vehicles for orally administered daunorubicin'. Together they form a unique fingerprint.

Cite this